Press Release

CD BIOPARTICLES LAUNCHES NEW LINE OF PARTICLES FOR SOLID PHASE ORGANIC SYNTHESIS



CD Bioparticles Launches New Line of Particles for Solid Phase Organic Synthesis

FOR IMMEDIATE RELEASE

22/02/2024

With years of experience in the pharmaceutical and life science sectors, CD Bioparticles has announced the expanded portfolio of its new Particles for Solid Phase Organic Synthesis, including functional resins, preloaded resins and resins for special synthesis, providing a more efficient and time-saving method for the synthesis of small molecules, peptides and oligonucleotides.

Solid Phase Organic Synthesis (SPOS) is a method in which molecules are covalently attached to a solid support and chemically synthesized stepwise using selective protecting groups. This method offers many significant advantages over conventional solution phase synthesis methods, including purification of the product by simple filtration of the polymer matrix, automation, ease of handling, low moisture susceptibility, minimal side reactions, no need for polymerization due to targeted separation of polymer particles, and recyclability of the polymer matrix for reuse. As a result, the time required for separation is very short and predictable.

The traditional support materials are polystyrene (PS)-based resins and polyethylene glycol (PEG)-grafted PS resins. The presence of PEG makes the resins compatible with polar solvents, especially water. SPOS is widely used in organic synthesis, particularly in the field of drug discovery, where efficient synthesis is highly desirable for high-throughput screening and optimization. In addition, with the advent of solid-phase technology, solid-phase peptide synthesis (SPPS) has become a more practical part of scientific research today.

CD Bioparticles now offers a range of functional resins and preloaded resins to meet the needs of small molecule, peptide, and oligonucleotide synthesis. Available in a variety of diameters (from 40 µm to 560 µm) and linker types, these SPOS particles offer excellent chemical and mechanical stability, efficient isolation of intermediates, and improved reaction conversions, making them well suited for high-efficiency synthesis.

The particles can be used in a wide range of applications, including general peptide synthesis, long peptide synthesis, small molecule synthesis involving acylation and alkylation, Michael addition, reductive amination, oligonucleotide synthesis, and multi-antigen peptide synthesis for polymerization of immunoconjugates.

For example, the DiagSupport™ H-Ala-2-Chlorotrityl Polystyrene/DVB Resin (Cat. No. SPS-AP23-001) have a copolymer matrix of copolymerized (styrene-1% DVB) and a particle size of 100-200 mesh. Since the attached amino acids are N-deprotected, these resins can be used without pretreatment. The resins are very acid sensitive and suitable for the synthesis of protected peptide fragments by Fmoc strategies. The finished peptides can be cleaved under very mild conditions to obtain protected peptides for further processing or under standard acidic conditions to obtain fully deprotected peptides.

These new offerings hold great promise for researchers and scientists in the field of organic synthesis. For more information about CD Bioparticles' new particles for SPOS, please visit https://www.cd-bioparticles.com/products/particles-for-solid-phase-organic-synthesis-1074.html.

About CD Bioparticles

CD Bioparticles is a leading manufacturer and supplier of various nanoparticles, microparticles, and coatings for R&D as well as commercialization across different application areas, including in vitro diagnostics, biochemistry, cellular analysis, cell separation, and immunoassay. The company also offers various custom services, including chemical surface-functionalization, fluorescent modification, antibody immobilization, as well as nucleic acid and oligo conjugation to meet client specifications.

Tags:
Solid Phase Organic Synthesis  |  CD Bioparticles  |  

---

Organisation Profile:
CD Bioparticles is an established drug delivery company which provides customized solutions for developing and producing new, biocompatible drug delivery systems.






Press release contact details for CD Bioparticles

NameCD Bioparticles
Tel1-631-346-0027
Fax
Email
Websitehttps://www.cd-bioparticles.net/
OrganisationCD Bioparticles
Address
Town
County0
Postcode




Other press releases from CD Bioparticles

CD Bioparticles Launches Gene Silencing for Bio-research Application
CD Bioparticles Launches Gel Permeation Chromatography Resins
CD Bioparticles Introduces Reversed Phase Chromatography Resins for Biological Analysis
CD Bioparticles Launches mRNA Transfection Reagents for Research Applications
CD Bioparticles Launches Normal Phase Chromatography Resins for Chromatographic Analysis
CD Bioparticles Launches 3D Transfection Reagents for Bio-research Applications
CD Bioparticles Launches Affinity Chromatography Resins for Laboratory Usage
CD Bioparticles Announces Carrageenans for Scientific Applications
CD Bioparticles Launches New Chromatography Resins for Improved Analysis and Preparation of Chiral Compounds
CD Bioparticles Launches New Alginic Acids for Research Applications
CD Bioparticles Launches Locust Bean Gum for Biopharmaceutical Applications
CD Bioparticles Announces New PLGA-Based Drug Delivery Systems for In Vitro and In Vivo Applications
CD Bioparticles Launches New Line of Bioinks for 3D Bioprinting
CD Bioparticles Launches New Quantum Dots Labeling & Conjugation Kits
CD Bioparticles Introduces New Extraction and Purification Kits for Rapid and Reliable DNA Isolation
CD Bioparticles Launches New Tissue Engineering Scaffolds for Researchers
CD Bioparticles Launches New Line of Polystyrene Particles Conjugated with Biomolecules
CD Bioparticles Launches 3D Cell Culture Substrate for Bio-research
CD Bioparticles Announces the Launch of New Flow Cytometry Particles
CD Bioparticles Introduces the Launch of Engineered Tissue Scaffolds
CD Bioparticles Announces Polyamino Acids for Drug Delivery Applications
CD Bioparticles Launches New Line of Functional Polystyrene Particles
CD Bioparticles Announces Expanded Offerings of Polydimethylsiloxane for Cutting-Edge Research
CD Bioparticles Unveils Versatile Plain Polystyrene Particles for Diverse Bioresearch Applications
CD Bioparticles Launches New Range of Low PDI Polymers for Drug Delivery Applications
CD Bioparticles Launches New Line of Particles for Solid Phase Organic Synthesis
CD Bioparticles Introduces Innovative Agarose Particles for Purification of Proteins and Antibodies
CD Bioparticles Announces New Line of Polyacrylamides for Drug Delivery Studies
CD Bioparticles Announces Versatile Basic Agarose Particles for Efficient Biomolecule Separation
CD Bioparticles Introduces New Polyolefin Family Polymers for Drug Delivery Applications
CD Bioparticles Announces New Line of Conjugated Agarose Particles for Affinity Separation and Purification
CD Bioparticles Announces Offering of Polystyrene Family Polymers for Drug Delivery
CD Bioparticles Announces Comprehensive Assay Portfolio for mRNA-LNP Vaccine Development
CD Bioparticles Introduces Functional Agarose Particles for Biomedical Research Applications
CD Bioparticles Announces Advanced Capabilities in Customized Liposomes for Targeted Delivery
CD Bioparticles Simplifies Multi-Analyte Detection with Advanced Multiplex Particles

Disclaimer:
Issuers of the press releases are solely responsible for the content of their press releases. Connect2business.co.uk cannot be held liable for the content posted by others to this website.